We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.2%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.36B
AUM Growth
-$521M
Cap. Flow
-$561M
Cap. Flow %
-16.68%
Top 10 Hldgs %
31.32%
Holding
2,193
New
694
Increased
377
Reduced
430
Closed
579
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CZOO
1426
CALL
DELISTED
Cazoo Group Ltd
CZOO
$119K ﹤0.01%
6
VIEW
1427
DELISTED
View, Inc. Class A Common Stock
VIEW
$116K ﹤0.01%
228
-22
-9% -$10.8K
TARA icon
1428
Protara Therapeutics
TARA
$232M
$114K ﹤0.01%
+11,700
New +$133K
ATSPU
1429
DELISTED
Archimedes Tech SPAC Partners Co. Unit
ATSPU
$114K ﹤0.01%
11,427
+43
+0.4% +$428
PSFE.WS
1430
DELISTED
Paysafe Ltd Warrants
PSFE.WS
$113K ﹤0.01%
+31,500
New +$120K
OPTN
1431
DELISTED
OptiNose
OPTN
$112K ﹤0.01%
2,400
+800
+50% +$40.9K
KIIIU
1432
DELISTED
Kismet Acquisition Three Corp. Unit
KIIIU
$110K ﹤0.01%
11,002
+2
+0% +$20
GMBL
1433
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
0
MONCU
1434
DELISTED
Monument Circle Acquisition Corp. Unit
MONCU
$109K ﹤0.01%
10,892
-665
-6% -$6.64K
QDROU
1435
DELISTED
Quadro Acquisition One Corp. Unit
QDROU
$109K ﹤0.01%
11,000
DMK
1436
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$107K ﹤0.01%
+1,394
New +$84.9K
TSIB
1437
DELISTED
Tishman Speyer Innovation Corp. II Class A common stock
TSIB
$106K ﹤0.01%
+10,660
New +$105K
ADF.U
1438
DELISTED
Aldel Financial Inc Units
ADF.U
$105K ﹤0.01%
+10,247
New +$103K
NGCA
1439
DELISTED
NextGen Acquisition Corp. II Class A Ordinary Shares
NGCA
$103K ﹤0.01%
+10,000
New +$100K
OCAX
1440
DELISTED
OCA Acquisition Corp. Class A Common Stock
OCAX
$102K ﹤0.01%
+10,319
New +$102K
GNCA
1441
DELISTED
Genocea Biosciences, Inc.
GNCA
$102K ﹤0.01%
+43,643
New +$105K
FZT.U
1442
DELISTED
FAST Acquisition Corp. II Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant
FZT.U
$100K ﹤0.01%
10,000
-20,000
-67% -$200K
TETCU
1443
DELISTED
Tech and Energy Transition Corporation Unit
TETCU
$100K ﹤0.01%
10,001
-194,999
-95% -$1.95M
KVSC
1444
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
$99K ﹤0.01%
10,022
-410
-4% -$4.11K
GROV icon
1445
Grove Collaborative
GROV
$46.1M
$98K ﹤0.01%
+2,000
New +$98.1K
CSTA
1446
DELISTED
Constellation Acquisition Corp I
CSTA
$98K ﹤0.01%
+10,000
New +$98.1K
SPKB
1447
DELISTED
Silver Spike Acquisition Corp II Class A Ordinary Shares
SPKB
$98K ﹤0.01%
+10,000
New +$98.2K
GGPI
1448
DELISTED
Gores Guggenheim, Inc. Class A Common Stock
GGPI
$98K ﹤0.01%
+10,000
New +$97.9K
VEEA
1449
Veea Inc
VEEA
$8.74M
$97K ﹤0.01%
+10,000
New +$97.9K
ROSS
1450
DELISTED
Ross Acquisition Corp II
ROSS
$97K ﹤0.01%
+10,000
New +$97.3K

Similar funds

Prelude Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Prelude Capital Management held 2,193 positions worth $3.36B, down 13% from $3.89B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Prelude Capital Management withdrew a net $561M in Q2 2021, closing 579 positions and reducing 430 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $39.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9% of assets, up from 6.6% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in KKR Acquisition Holdings I Corp. worth $36.3M.

  • Prelude Capital Management's largest Q2 2021 buy was KKR Acquisition Holdings I Corp.: 3,700,000 shares worth $36.3M.
  • Prelude Capital Management added most to PRA Health Sciences, Inc. in Q2 2021, an estimated $19.4M increase.
  • Prelude Capital Management's biggest Q2 2021 reduction was Micron Technology, cutting an estimated $7.72M.
  • Prelude Capital Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2021, selling an estimated $39.4M.
  • Prelude Capital Management's ten largest holdings make up 31% of its $3.36B portfolio in Q2 2021.
  • Prelude Capital Management opened 694 new positions and closed 579 in Q2 2021.
  • Prelude Capital Management's portfolio value fell 13% quarter-over-quarter to $3.36B.

Based on Prelude Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.